Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/15295
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChanpattana W.
dc.date.accessioned2021-04-05T04:33:26Z-
dc.date.available2021-04-05T04:33:26Z-
dc.date.issued2000
dc.identifier.issn10950680
dc.identifier.other2-s2.0-0034199344
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/15295-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0034199344&doi=10.1097%2f00124509-200006000-00013&partnerID=40&md5=df3a98fda3febcb668df544b04f22ddb
dc.description.abstractA treatment-resistant manic patient failed to respond to conventional treatment, adjunctive olanzapine (20 mg/day), clozapine (600 mg/day), or ECT alone, but did respond to ECT combined with low dose clozapine (200 mg/day). Maintenance ECT combined with clozapine resulted in a remission over the 18-month period.
dc.subjectclozapine
dc.subjectneuroleptic agent
dc.subjectadult
dc.subjectarticle
dc.subjectbipolar disorder
dc.subjectcase report
dc.subjectelectroconvulsive therapy
dc.subjecthuman
dc.subjectlong term care
dc.subjectmale
dc.subjectmultimodality cancer therapy
dc.subjectAdult
dc.subjectAntipsychotic Agents
dc.subjectBipolar Disorder
dc.subjectClozapine
dc.subjectCombined Modality Therapy
dc.subjectElectroconvulsive Therapy
dc.subjectHumans
dc.subjectLong-Term Care
dc.subjectMale
dc.titleCombined ECT and clozapine in treatment-resistant mania
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of ECT. Vol 16, No.2 (2000), p.204-207
dc.identifier.doi10.1097/00124509-200006000-00013
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.